Morfin (Morphine Sulfate Pentahydrate)

Morphine, the active ingredient in Morfin, is an opioid analgesic presented as an oral formulation for systemic use. It is indicated for the management of moderate to severe pain in adult patients when other analgesics are insufficient. GNH USA supplies Morfin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Morphine acts on the central nervous system to relieve pain across several clinical contexts. - Moderate to severe acute pain: provides rapid analgesia to reduce pain intensity. - Post‑operative pain: controls pain following surgical procedures. - Cancer‑related pain: alleviates severe malignant pain when other treatments are inadequate.

Morphine may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea: feeling of sickness often accompanied by an urge to vomit. - Constipation: reduced bowel movements and hard stools. - Drowsiness: increased sleepiness or reduced alertness. - Dry mouth: decreased salivation leading to a parched feeling. - Dizziness: sensation of light‑headedness or unsteadiness. - Vomiting: expulsion of stomach contents.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure causing faintness. - Anaphylactic reaction: sudden, severe allergic response with rash, swelling, and airway compromise. - Adrenal insufficiency: impaired cortisol production leading to fatigue and weakness. - Seizures: rare occurrence of convulsive episodes.

When prescribing or dispensing Morfin, several safety considerations are essential. - Assess pain severity: confirm that opioid therapy is appropriate for the patient's pain level. - Monitor respiratory function: watch for signs of slowed breathing, especially after dose initiation. - Evaluate hepatic and renal function: adjust dosing in patients with organ impairment. - Use caution in the elderly: increased sensitivity to sedative effects and risk of falls. - Avoid in patients with acute asthma or severe respiratory compromise: risk of fatal respiratory depression. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Morphine can interact with other medicines, altering its safety or effectiveness.

Major Interactions (Avoid): - Central nervous system depressants (e.g., benzodiazepines): may cause profound sedation or respiratory depression. - Monoamine oxidase inhibitors (MAOIs): increase risk of severe hypertension or serotonin syndrome. - Other opioids: additive opioid effect can lead to respiratory failure.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin): may raise morphine plasma levels. - CYP3A4 inducers (e.g., rifampin): may reduce morphine effectiveness. - Diuretics: can enhance hypotensive effects when combined with morphine.